Change in lipid profile and risk of new-onset atrial fibrillation in patients with chronic heart failure: A 3-year follow-up observational study in a large Chinese hospital.

Chen Liu,Jin Geng,Xiao Ye,Xiaochen Yuan,Aihua Li,Zhengang Zhang,Biao Xu,Yingwei Wang
DOI: https://doi.org/10.1097/MD.0000000000012485
IF: 1.6
2018-01-01
Medicine
Abstract:In chronic heart failure (CHF), new-onset atrial fibrillation (AF) is associated with increased morbidity and mortality. We aimed to evaluate the influence of dyslipidemia on the incidence of new-onset AF in patients with CHF. In this single-center observational study, 308 patients with CHF and no history of AF were followed-up for 3 years. Of the 291 patients who attended the 1-year follow-up, 78 had developed AF (AF group; 10 deaths), while 213 had not (sinus rhythm [SR] group). Changes in lipid profile (Delta TC for total cholesterol and Delta LDLc for low-density lipoprotein cholesterol) were analyzed. The groups differed significantly regarding the decrease in lipid levels from baseline to the 1-year follow-up (AF vs SR: for Delta LDLc, 23.35 vs 7.80 mg/dL, P = .02; for Delta TC, 23.95 vs -2.76mg/dL, P = .001). At the 3-year follow-up, new-onset AF was noted in 21 of the 188 living patients in the SR group. Cox proportional hazards analysis revealed Delta LDLc and Delta TC as independent risk factors for new-onset AF (hazard ratio, 1.018 and 1.013, respectively, per standard deviation increment), with higher incidence of new-onset AF for Delta TC > 9.65mg/dL (P = .02) and for Delta LDLc > 9.73mg/dL (P = .005). In CHF, pronounced decrease in LDLc and TC is associated with new-onset AF.
What problem does this paper attempt to address?